Lifecore Biomedical (LDE) Stock Statistics & Valuation Metrics
Total Valuation
Lifecore Biomedical has a market cap or net worth of EUR 217.22M. The enterprise value is EUR 386.59M.
- Market Cap
- EUR 217.22M
- Enterprise Value
- EUR 386.59M
Share Statistics
Lifecore Biomedical has 37,905,846 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 37,905,846
- Owned by Insiders
- 15.99%
- Owned by Institutions
- 14.08%
Financial Efficiency
Lifecore Biomedical’s return on equity (ROE) is 2.17 and return on invested capital (ROIC) is -0.60%.
- Return on Equity (ROE)
- 2.17
- Return on Assets (ROA)
- -0.13
- Return on Invested Capital (ROIC)
- -0.60%
- Return on Capital Employed (ROCE)
- -0.01
- Revenue Per Employee
- 338.91K
- Profits Per Employee
- -80.60K
- Employee Count
- 382
- Asset Turnover
- 0.56
- Inventory Turnover
- 3.06
Valuation Ratios
The current PE Ratio of Lifecore Biomedical is -5.82. Lifecore Biomedical’s PEG ratio is 0.47.
- PE Ratio
- -5.82
- PS Ratio
- 1.98
- PB Ratio
- 14.94
- Price to FCF
- -135.00
- Price to Operating Cash Flow
- 115.39
- PEG Ratio
- 0.47
Income Statement
In the last 12 months, Lifecore Biomedical had revenue of 129.46M and earned -30.79M in profits. Earnings per share was -0.92.
- Revenue
- 129.46M
- Gross Profit
- 40.61M
- Operating Income
- -1.26M
- Pretax Income
- -30.21M
- Net Income
- -30.79M
- EBITDA
- 8.24M
- Earnings Per Share (EPS)
- -0.92
Cash Flow
In the last 12 months, operating cash flow was 3.05M and capital expenditures -3.15M, giving a free cash flow of -106.28K billion.
- Operating Cash Flow
- 3.05M
- Free Cash Flow
- -106.28K
- Free Cash Flow per Share
- -0.05
Dividends & Yields
Lifecore Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.74%
- Earnings Yield
- -15.50%
Stock Price Statistics
- Beta
- 1.15
- 52-Week Price Change
- -4.20%
- 50-Day Moving Average
- 4.59
- 200-Day Moving Average
- 4.60
- Relative Strength Index (RSI)
- 72.39
- Average Volume (3m)
- 1,841
Important Dates
Lifecore Biomedical upcoming earnings date is May 12, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- May 12, 2027
- Ex-Dividend Date
- ―
Financial Position
Lifecore Biomedical as a current ratio of 3.49, with Debt / Equity ratio of -1004.14%
- Current Ratio
- 3.49
- Quick Ratio
- 2.26
- Debt to Market Cap
- 0.50
- Net Debt to EBITDA
- 15.18
- Interest Coverage Ratio
- 0.57
Taxes
In the past 12 months, Lifecore Biomedical has paid 577.71K in taxes.
- Income Tax
- 577.71K
- Effective Tax Rate
- -0.02
Enterprise Valuation
Lifecore Biomedical EV to EBITDA ratio is -91.91, with an EV/FCF ratio of -211.70.
- EV to Sales
- 3.10
- EV to EBITDA
- -91.91
- EV to Free Cash Flow
- -211.70
- EV to Operating Cash Flow
- 182.55
Balance Sheet
Lifecore Biomedical has EUR 17.47M in cash and marketable securities with EUR 142.61M in debt, giving a net cash position of -EUR 125.14M billion.
- Cash & Marketable Securities
- EUR 17.47M
- Total Debt
- EUR 142.61M
- Net Cash
- -EUR 125.14M
- Net Cash Per Share
- -EUR 3.30
- Tangible Book Value Per Share
- -EUR 1.28
Margins
Gross margin is 29.68%, with operating margin of -2.12%, and net profit margin of -30.40%.
- Gross Margin
- 29.68%
- Operating Margin
- -2.12%
- Pretax Margin
- -30.06%
- Net Profit Margin
- -30.40%
- EBITDA Margin
- -3.38%
- EBIT Margin
- -10.98%
Analyst Forecast
The average price target for Lifecore Biomedical is EUR 5.65, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- EUR 5.65
- Price Target Upside
- 0.96% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 4
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 2
- AI Score
- ―
